PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Clinical trials for PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial aims to boost immune system to fight tough blood cancers
Disease control OngoingThis early-stage study is testing the safety and best dose of a two-drug combination for people with aggressive forms of blood cancer (myelodysplastic syndrome or acute myeloid leukemia) that have returned or not responded to prior treatments. The trial combines a chemotherapy dr…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New radiation technique tested in fight against relapsed blood cancers
Disease control TerminatedThis study is testing a new, more targeted form of radiation to the bone marrow (called IMTMI) given with two chemotherapy drugs before a second stem cell transplant. The goal is to see if this combination is safe and can better prepare patients with advanced blood cancers (like …
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC